Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

Nature communications

Hengrui Liu, Sho Iketani, Arie Zask, …, Alejandro Chavez, David D Ho, Brent R Stockwell

• DOI: 10.1038/s41467-022-29413-2
• PMID: 35393402
• PMCID: PMC8989888